Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investor Eye: Novalis Embraces Early Investment And Enabling Technology

Executive Summary

Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.

You may also be interested in...



Minute Insight: Olympus Corporation Joins VC Race With Its Own Fund

The Japanese company is hoping to access breaking technologies sooner via earlier investment.

Medtech Companies Face Challenges And Choices When Going Public

In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.

Start-Up Spotlight: Grapheal Unlocking Graphene’s Potential In Wound Healing

The company has developed a biosensor that provides information to health care professionals concerning the health of a patient’s wound.

Related Content

Topics

UsernamePublicRestriction

Register

MT143715

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel